financetom
Business
financetom
/
Business
/
Park Hotels & Resorts JV Sells Spokane, Washington, Hotel for $35 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Park Hotels & Resorts JV Sells Spokane, Washington, Hotel for $35 Million
Dec 5, 2024 8:07 AM

10:51 AM EST, 12/05/2024 (MT Newswires) -- Park Hotels & Resorts ( PK ) said Thursday that the consolidated joint venture that owns DoubleTree Hotel Spokane City Center in Washington sold the property for $35 million in gross proceeds.

The company said the sale proceeds will go toward the repayment of the $13.5 million mortgage on the property. Park Hotels' pro rata share of the remaining net proceeds will be used for general corporate purposes.

So far this year, the company said it has sold or disposed of three hotels for about $76 million in gross proceeds.

Park Hotels shares were up 2% in recent trading.

Price: 16.13, Change: +0.31, Percent Change: +1.95

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Warner Bros Discovery plans two-way split aiming for potential cable deal
Warner Bros Discovery plans two-way split aiming for potential cable deal
Dec 12, 2024
(Reuters) -Warner Bros Discovery on Thursday decided to separate its declining cable TV business from the streaming and studio operations, laying the groundwork for a potential sale or spinoff of its TV business as cord-cutting picks up pace. Its shares rose about 7% in early trading as the company said the new corporate structure will provide more options for further...
Keros Therapeutics Loses 75% Value In A Single Session - Here's Why
Keros Therapeutics Loses 75% Value In A Single Session - Here's Why
Dec 12, 2024
On Thursday, Keros Therapeutics, Inc. ( KROS ) voluntarily halted dosing in the 3.0 mg/kg and 4.5 mg/kg treatment arms in the ongoing TROPOS trial Phase 2 trial of cibotercept (KER-012) in combination with background therapy in pulmonary arterial hypertension patients. The move is based on a safety review, as the trial unanticipatedly observed adverse pericardial effusion events. Also Read:...
Brazil's auto production to grow 6.8% in 2025, Anfavea says
Brazil's auto production to grow 6.8% in 2025, Anfavea says
Dec 12, 2024
SAO PAULO, Dec 12 (Reuters) - Brazil's auto production is expected to rise 6.8% in 2025 from this year, totaling 2.75 million units, estimates released by automakers association Anfavea showed on Thursday. Auto sales in Latin America's largest economy, the group added, are set to grow 5.6% next year to 2.8 million units. ...
Market Chatter: Starboard Value Takes Large Stake in Riot Platforms
Market Chatter: Starboard Value Takes Large Stake in Riot Platforms
Dec 12, 2024
09:30 AM EST, 12/12/2024 (MT Newswires) -- Activist Investor Starboard Value has built a large position in Riot Platforms ( RIOT ) and is looking to make changes at the bitcoin-mining operator, The Wall Street Journal reported Thursday, citing people familiar with the matter. Riot did not immediately respond to a request for comment from MT Newswires. (Market Chatter news...
Copyright 2023-2026 - www.financetom.com All Rights Reserved